A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP
A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP
Zachary Abuza
Opinion

Opinion

Zachary Abuza

As China doles out coronavirus vaccine in Southeast Asia, US withers in a leadership vacuum

  • Beijing’s success in stopping the spread of Covid-19 is a source of soft power that will be magnified by providing vaccines in the region
  • Washington, meanwhile, has earned no capital in its approach to vaccine diplomacy – indeed, its parsimoniousness may be causing harm

A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP
A worker loads vials to be used in the production line for a Covid-19 vaccine at Chinese company Sinovac in Beijing. Photo: AP
READ FULL ARTICLE